Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate topical treatment with Veregen™ 15% ointment as a
single therapeutic agent and compare it to combination therapy with Veregen ™ 15% ointment
and a single destructive treatment by cryotherapy for non-facial verruca vulgaris in the
pediatric population. This novel treatment modality may be useful in the pediatric
dermatology community offering a less invasive, painless option for treatment of non-facial
verruca vulgaris.